Search

The ability to make insulin was one of the great medical breakthroughs of the 20th Century. However, it quickly became clear to clinicians and researchers how complicated the human body's systems were for regulating and using blood sugar. In the absence of a deep understanding of these systems, providing insulin could have dangers.

Infants are vulnerable to health challenges because of the relatively immature state of their bodies, including their nervous, cardiovascular and respiratory systems. Moreover, an infant may appear completely healthy but still have an underlying vulnerability that can make it difficult for that infant to cope with certain kinds of environmental stress. 

This handbook outlines the requirements and procedures for the certification of institutions under our National Certification Scheme of Institutional Processes Related to the Ethical Review of Multi-centre Research. The handbook is currently under review. Before commencing steps to apply for certification, please contact us at HREC.admin@nhmrc.gov.au for further advice.

Pharmaxis Ltd is an Australian pharmaceutical research company established in 1998. It listed on the Australian Securities Exchange (ASX) in 2003. The business focuses on new therapies to treat inflammation and fibrosis with a portfolio of products at various stages of development and approval. With origins in clinical research, this Australian-owned start up successfully competes in an international market.

Sapphire is NHMRC's solution for supporting end-to-end management of all Medical Research Endowment Account (MREA) grant opportunities (GOs) as well as Medical Research Future Fund (MRFF) GOs administered by NHMRC on behalf of the Department of Health, Disability and Ageing.

Around 1,786 new cases of ovarian cancer in Australia were estimated to have been diagnosed in 2023, which is the equivalent of a 1 in 87 lifetime risk.In our first Speaking of Science webinar, held for Ovarian Cancer Awareness Month, we were joined by international expert in ovarian cancer research, Professor Susan Ramus (Professor of Molecular Oncology in the School of Clinical Medicine at the University of New South Wales).

NHMRC is investing almost $20 million towards Australian health and medical research partnerships between researchers, decision makers, policy makers, managers and clinicians.

The Good institutional practice guide (the Guide) brings together information on values, concepts and ideas that underpin a high-quality research culture. Although developed to support institutional and research leaders as they implement positive change, the Guide can be used by anyone involved with the conduct, administration and oversight of research.A PDF version of the complete Guide is available from the Downloads section.

This section provides a collation of the self-reflection questions in the Good institutional practice guide (the Guide), that can be used by leaders to determine their stage of implementation of cultural change.

This section provides a collation of the case studies and scenarios provided in the Good institutional practice guide (the Guide).

Section 3 describes the approach taken in the Good institutional practice guide (the Guide) for implementing cultural change and Section 4 provides practical guidance.

Section 1 describes values that support an open, honest, supportive and respectful research culture that is conducive to the conduct of high-quality research. Section 2 discusses the key elements integral to shaping research culture.

This section includes definitions of terms and explanations of abbreviations used in Good institutional practice guide (the Guide).

This section includes examples of relevant international initiatives and activities, as well as general resources for specific topics.

This section provides frequently asked questions about the Good institutional practice guide (the Guide).

Mannitol is a naturally occurring sugar alcohol from the sap of the manna ash tree that can be produced as a dry powder. In the 1990s, Dr Sandra Anderson and colleagues at Sydney's Royal Prince Alfred Hospital (RPAH) began research into how inhaled mannitol can be used to diagnose asthma. This work resulted in the development of two new pharmaceutical products, Aridol® and Bronchitol®.

The Australian Government commissioned a review of the clinical effectiveness of 16 natural therapies excluded from private health insurance rebates in April 2019. The Department of Health and Aged Care engaged National Health and Medical Research Council (NHMRC) to assist in its review by commissioning evidence evaluations that assessed published scientific research on the excluded therapies. NHMRC completed its role in the Natural Therapies Review 2024 with submission of all finalised evidence evaluations to the Department of Health and Aged Care in January 2025.

Cultural factors critical to the health and wellbeing of Aboriginal and Torres Strait Islander adults have been assessed in the largest cohort study ever, conducted by Professor Raymond Lovett, yielding a new resource for health practitioners, policymakers and Indigenous communities.